OGT Says Licensing Deals Could Ease IP 'Confusion,' Stimulate Growth in Japanese Microarray Market | GenomeWeb
Oxford Gene Technology said this week that it has signed licensing deals with Japanese firms Bio Matrix Research and Filgen that will give the companies access to OGT’s intellectual property covering the manufacture and marketing of oligonucleotide microarrays.
 
The two new deals come just weeks after OGT announced similar licensing arrangements with NGK Insulators and Yamatake, and could herald a proliferation of new chips and services in the Japanese microarray market, according to an OGT official.
 

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PLOS this week: genetic study of breast cancer in Egyptian families, mutations linked to cleft lip and palate, and more.

Council Bluffs, Iowa, schools are encouraging more girls to pursue STEM courses, according to the Associated Press.

Because of new open-access requirements, Gates Foundation-funded researchers can't publish in some top journals, Nature News reports.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.